Literature DB >> 25483062

Sex differences in aging, life span and spontaneous tumorigenesis in 129/Sv mice neonatally exposed to metformin.

Vladimir N Anisimov1, Irina G Popovich, Mark A Zabezhinski, Peter A Egormin, Maria N Yurova, Anna V Semenchenko, Margarita L Tyndyk, Andrey V Panchenko, Alexandr P Trashkov, Andrey G Vasiliev, Nikolai V Khaitsev.   

Abstract

The perinatal (prenatal and early neonatal) period is a critical stage for hypothalamic programming of sexual differentiation as well as for the development of energy and metabolic homeostasis. We hypothesized that neonatal treatment with antidiabetic drug biguanide metformin would positively modify regulation of growth hormone--IGF-1--insulin signaling pathway slowing down aging and improving cancer preventive patterns in rodents. To test this hypothesis male and female 129/Sv mice were s.c. injected with metformin (100 mg/kg) at the 3rd, 5th and 7th days after birth. Metformin-treated males consumed less food and water and their body weight was decreased as compared with control mice practically over their entire lifespan. There were no significant differences in age-related dynamics of food and water consumption in females and they were heavier than controls. The fraction of mice with regular estrous cycles decreased with age and demonstrated a tendency to decrease in the females neonatally treated with metformin. Neonatal exposure to metformin practically failed to change the extent of hormonal and metabolic parameters in blood serum of male and female mice. In males, neonatal metformin treatment significantly increased the mean life span (+20%, P < 0.05) and slightly increased the maximum life span (+3.5%). In females, the mean life span and median in metformin-treated groups were slightly decreased (-9.1% and -13.8% respectively, P > 0.05) in comparison to controls, whereas mean life span of last 10% survivors and maximum life span were the same as in controls. Almost half (45%) of control male mice and 71.8% male mice neonatally exposed to metformin survived up to 800 d of age, the same age was achieved by 54.3% of mice in control female group and 30% of metformin-treated females (P < 0.03). Thus, neonatal metformin exposure slows down aging and prolongs lifespan in male but not in female mice.

Entities:  

Keywords:  biomarkers of aging; carcinogenesis; gender; life extension; metformin; mice; neonatal

Mesh:

Substances:

Year:  2015        PMID: 25483062      PMCID: PMC4353070          DOI: 10.4161/15384101.2014.973308

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

Review 1.  Calorie restriction mimetics: an emerging research field.

Authors:  Donald K Ingram; Min Zhu; Jacek Mamczarz; Sige Zou; Mark A Lane; George S Roth; Rafael deCabo
Journal:  Aging Cell       Date:  2006-04       Impact factor: 9.304

Review 2.  Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis.

Authors:  Barry E Levin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  Metformin supplementation and life span in Fischer-344 rats.

Authors:  Daniel L Smith; Calvin F Elam; Julie A Mattison; Mark A Lane; George S Roth; Donald K Ingram; David B Allison
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-19       Impact factor: 6.053

4.  Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.

Authors:  Vladimir N Anisimov; Peter A Egormin; Tatiana S Piskunova; Irina G Popovich; Margarita L Tyndyk; Maria N Yurova; Mark A Zabezhinski; Ivan V Anikin; Arseniy S Karkach; Alexey A Romanyukha
Journal:  Cell Cycle       Date:  2010-01-22       Impact factor: 4.534

5.  Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling.

Authors:  Brendan J Quinn; Matthew Dallos; Hiroshi Kitagawa; Ajaikumar B Kunnumakkara; Regan M Memmott; M Christine Hollander; Joell J Gills; Phillip A Dennis
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-14

6.  Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice.

Authors:  V M Dilman; V N Anisimov
Journal:  Gerontology       Date:  1980       Impact factor: 5.140

Review 7.  Methods of evaluating the effect of pharmacological drugs on aging and life span in mice.

Authors:  Vladimir N Anisimov; Irina G Popovich; Mark A Zabezhinski
Journal:  Methods Mol Biol       Date:  2007

Review 8.  Metformin and polycystic ovary syndrome: a literature review.

Authors:  Khalid A Awartani; Anthony P Cheung
Journal:  J Obstet Gynaecol Can       Date:  2002-05

9.  Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.

Authors:  Henriikka Salomäki; Laura H Vähätalo; Kirsti Laurila; Norma T Jäppinen; Anna-Maija Penttinen; Liisa Ailanen; Juan Ilyasizadeh; Ullamari Pesonen; Markku Koulu
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

10.  M(o)TOR of aging: MTOR as a universal molecular hypothalamus.

Authors:  Mikhail V Blagosklonny
Journal:  Aging (Albany NY)       Date:  2013-07       Impact factor: 5.682

View more
  15 in total

Review 1.  Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.

Authors:  Silvio De Flora; Gancho Ganchev; Marietta Iltcheva; Sebastiano La Maestra; Rosanna T Micale; Vernon E Steele; Roumen Balansky
Journal:  Trends Pharmacol Sci       Date:  2015-12-23       Impact factor: 14.819

Review 2.  The road ahead for health and lifespan interventions.

Authors:  Marta Gonzalez-Freire; Alberto Diaz-Ruiz; David Hauser; Jorge Martinez-Romero; Luigi Ferrucci; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2020-02-25       Impact factor: 10.895

3.  Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes.

Authors:  Yun Zhu; Yimin Fang; David Medina; Andrzej Bartke; Rong Yuan
Journal:  Mech Ageing Dev       Date:  2021-11-12       Impact factor: 5.432

4.  Sex-specific effects of maternal metformin intervention during glucose-intolerant obese pregnancy on body composition and metabolic health in aged mouse offspring.

Authors:  Josca M Schoonejans; Heather L Blackmore; Thomas J Ashmore; Lucas C Pantaleão; Luciana Pellegrini Pisani; Laura Dearden; John A Tadross; Catherine E Aiken; Denise S Fernandez-Twinn; Susan E Ozanne
Journal:  Diabetologia       Date:  2022-09-16       Impact factor: 10.460

5.  Considerations Regarding Public Use of Longevity Interventions.

Authors:  Yasmine J Liu; Rebecca L McIntyre; Georges E Janssens
Journal:  Front Aging       Date:  2022-04-25

Review 6.  Metformin: A Hopeful Promise in Aging Research.

Authors:  Marta G Novelle; Ahmed Ali; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

Review 7.  Widespread sex dimorphism in aging and age-related diseases.

Authors:  Nirmal K Sampathkumar; Juan I Bravo; Yilin Chen; Prakroothi S Danthi; Erin K Donahue; Rochelle W Lai; Ryan Lu; Lewis T Randall; Nika Vinson; Bérénice A Benayoun
Journal:  Hum Genet       Date:  2019-11-01       Impact factor: 4.132

8.  Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients.

Authors:  Annalisa Noce; Maria Paola Canale; Ambrogio Capria; Valentina Rovella; Manfredi Tesauro; Giorgio Splendiani; Margherita Annicchiarico-Petruzzelli; Micol Manzuoli; Giovanni Simonetti; Nicola Di Daniele
Journal:  Aging (Albany NY)       Date:  2015-04       Impact factor: 5.682

Review 9.  Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules.

Authors:  Surinder Kumar; David B Lombard
Journal:  F1000Res       Date:  2016-03-29

10.  Gender Differences in Response to Prolonged Every-Other-Day Feeding on the Proliferation and Apoptosis of Hepatocytes in Mice.

Authors:  Katarzyna Piotrowska; Maciej Tarnowski; Katarzyna Zgutka; Andrzej Pawlik
Journal:  Nutrients       Date:  2016-03-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.